[(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-fluorophenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] 2-[(1R)-2-fluoro-2-methylcyclopropyl]acetate
C35H35ClF6N8O3 — CID 158064318
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-fluorophenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] 2-[(1R)-2-fluoro-2-methylcyclopropyl]acetate
[(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-fluorophenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] 2-[(1R)-2-fluoro-2-methylcyclopropyl]acetate (PubChem CID 158064318) has the molecular formula C35H35ClF6N8O3 and a molecular weight of 765.16 g/mol. Its IUPAC name is [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-fluorophenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] 2-[(1R)-2-fluoro-2-methylcyclopropyl]acetate.
Molecular Properties
| Compound Name | [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-fluorophenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] 2-[(1R)-2-fluoro-2-methylcyclopropyl]acetate |
|---|---|
| PubChem CID | 158064318 |
| Molecular Formula | C35H35ClF6N8O3 |
| Molecular Weight | 765.16 g/mol |
| Exact Mass | 764.24 |
| IUPAC Name | [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-fluorophenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] 2-[(1R)-2-fluoro-2-methylcyclopropyl]acetate |
| SMILES | CC(C)(C)C[C@]1(c2ccc(-c3cnn(C(F)F)c3)c(F)c2)N=C(N)N([C@H](COC(=O)C[C@@H]2CC2(C)F)c2ccc(Cl)c(-n3ncnc3C(F)F)c2)C1=O |
| InChI | InChI=1S/C35H35ClF6N8O3/c1-33(2,3)16-35(20-6-7-22(24(37)10-20)19-13-45-48(14-19)31(40)41)30(52)49(32(43)47-35)26(15-53-27(51)11-21-12-34(21,4)42)18-5-8-23(36)25(9-18)50-29(28(38)39)44-17-46-50/h5-10,13-14,17,21,26,28,31H,11-12,15-16H2,1-4H3,(H2,43,47)/t21-,26-,34?,35-/m1/s1 |
| InChIKey | CGVKRANXSQLPLC-HGMCVZNGSA-N |
| XLogP | 7.47 |
| TPSA | 133.52 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 765.16 |
| LogP ≤ 5 | 7.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158064318 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.